drugset / Trial / NCT00876226

Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome

NCT00876226

NaSingle-groupOpen-labelHealth-services research

Summary

This study will look at how the body interacts with citalopram in adult participants with short bowel syndrome. While information on depression in patients with short bowel syndrome is sparse, the investigators' experience is that these patients have a high incidence of depression and should benefit from a drug intervention.

Timeline

Start
2010-05-01
Primary completion
2012-09-11
Completion
2012-09-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 20 mg Oral

Indications